DYRK1A and cancer: Thus, these phosphorylation modifications of NPF and regulatory factors that can phosphorylate NPF, such as Shp1, Dyrk1A, Casein Kinase II, PAK4, SRC, ERK, Abl, Cdk5, etc., may provide targets for anti-invasive cancer therapy.